Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force

Rhabdomyosarcoma is the most common soft tissue sarcoma diagnosed in children and adolescents. Patients that are diagnosed with advanced or relapsed disease have exceptionally poor outcomes. The Children’s Oncology Group (COG) convened a rhabdomyosarcoma new agent task force in 2020 to systematicall...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacenta, Holly L., Allen-Rhoades, Wendy, Langenau, David, Houghton, Peter J., Keller, Charles, Heske, Christine M., Deel, Michael D., Linardic, Corinne M., Shern, Jack F., Stewart, Elizabeth, Turpin, Brian, Harrison, Douglas J., Khan, Javed, Mascarenhas, Leo, Skapek, Stephen X., Meyer, William H., Hawkins, Douglas S., Chen, Eleanor Y., Amatruda, James F., Hingorani, Pooja, Laetsch, Theodore W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037615/
https://www.ncbi.nlm.nih.gov/pubmed/33915882
http://dx.doi.org/10.3390/jcm10071416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037615/
https://www.ncbi.nlm.nih.gov/pubmed/33915882
http://dx.doi.org/10.3390/jcm10071416

Ejemplares similares